Idéal Investisseur
Français English
CAC 40 : Market closed
7 969,42 pts
-0.01%


Last updated : 30/10/2026 - 17h36
🏠 Home   ➤    Stock news

Agfa-Gevaert: Michel Govaert Resigns from the Board of Directors

Agfa-Gevaert announces the departure of Michel Govaert from the board of directors. The resignation of the independent member is effective immediately due to personal reasons.


Agfa-Gevaert: Michel Govaert Resigns from the Board of Directors

Immediate Effective Departure

Michel Govaert, serving as the permanent representative of MJP Management Services BV, has tendered his resignation as an independent member of the Agfa-Gevaert board of directors. The resignation takes effect from Wednesday, May 20, 2026. The board of directors expressed their gratitude towards Michel Govaert for his contributions and expertise during his tenure in the governance body.

Succession Procedure Initiated

Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning ✓ Euronext data ✓ AI-powered analysis

The Nomination and Remuneration Committee will soon initiate the procedure to fill the position.



Sector Dispositifs médicaux et optique › Dispositifs médicaux / imagerie


Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext

Context

Period
  • Period: S1 2026
Key reported figures
  • Revenue: 512 millions d'euros
  • Quarterly revenue: 512 millions d'euros
  • Revenue growth: -2,2 %
  • EBITDA: 25 millions d'euros
  • EBITDA margin: 4,9 %
  • Net income: -27 millions d'euros
  • Free cash flow: -52 millions d'euros
  • 127 millions d'euros
Guidance from the release
  • The full year 2026 free cash flow is expected to be more negative than in 2025
Risks mentioned
  • Flux de trésorerie disponible négatif de 52 M€ au S1 2026, aggravé par les coûts de transformation et de réorganisation
  • Faiblesse persistante du marché Green Hydrogen Solutions liée aux retards de mise en œuvre de la directive RED III
  • Baisse du chiffre d'affaires de HealthCare IT de 7,3% hors effet de change liée à la transition cloud
Opportunities identified
  • EBITDA ajusté du groupe en hausse de 66% au S1 2026 grâce aux programmes d'économies
  • Recettes récurrentes de HealthCare IT en hausse de 4% hors effet de change au T2 2026, où elles représentent 66% du chiffre d'affaires du segment
  • Amélioration du fonds de roulement dans toutes les activités hors film grâce à un programme d'affacturage avec BNP Paribas Fortis

The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.

Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.

Advertisement
Every morning
Technical market signals,
before the opening bell.
CAC 40 · SBF 120 · Signals · Analysts
🤖
Today's edition — pre-market
CAC 40
7 702
-0,87%
SBF 120
5 827
-0,87%
📈 Bullish signals
+5,2%
+1,8%
+0,9%
📉 Bearish signals
-14%
-5,7%
🔄 Analyst opinions
▲ 35 €
▼ 80 €
Sign up to see everything →
Before 9 AM every morning
Euronext data
AI-powered analysis





BOURSE · Chaque matin
La synthèse bourse,
avant l'ouverture.
Notre moteur analyse chaque nuit le CAC 40 et le SBF 120. Ce qui mérite attention remonte directement dans votre boîte mail. Gratuit.
✓ Avant 9h00 ✓ 1000+ inscrits ✓ 100% gratuit
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours sur les valeurs Euronext, chaque matin avant 9h.
tendance · 6 séances
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours